A Phase II Trial to Study BAY1753011 in Patients With Congestive Heart Failure (Q63578408)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase II Trial to Study BAY1753011 in Patients With Congestive Heart Failure |
clinical trial |
Statements
AVANTI (English)
0 references
A Multicenter, Randomized, Parallel Group, Double Blind, Active and Placebo Controlled Study of BAY1753011, a Dual V1a/V2 Vasopressin Receptor Antagonist, in Patients With Congestive Heart Failure: AVANTI Study (English)
0 references
15 May 2019
0 references
21 June 2020
0 references
414
0 references
18 year
0 references
85 year
0 references